Cerebral microbleed mimics

Cerebral Microbleeds: Pathophysiology to Clinical Practice

Volumn , Issue , 2011, Pages 44-48

  Samarasekera, Neshika ^a   Potter, Gillian ^a   Salman, Rustam Al Shahi ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84879206730     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511974892.008     Document Type: Chapter

References (18)

1. Greenberg SM, Vernooji MW, Cordonnier C et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol 2009;8:165-74.
2. Cordonnier C, Al-Shahi Salman R, Wardlaw JM. Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain 2007;130:1988-2003.
3. Cordonnier C, Potter GM, Jackson CA et al. Improving interrater agreement about brain microbleeds: development of the Brain Observer MicroBleed Scale (BOMBS). Stroke 2009;40:94-9.
4. Gregoire SM, Chaudary UJ, Brown MM et al. The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology 2009;73:1759-66.
5. Casanova MF, Araque JM. Mineralization of the basal ganglia: implications for neuropsychiatry, pathology and neuroimaging. Psychiatry Res 2003;121:59-87.
6. 2-weighted gradient echo magnetic resonance imaging. J Neurol Neurosurg Psychiatry 2007;78:871.
7. Almansori M, Naik S, Ahmed SN. Magnetic susceptibility in a patient with a metallic heart valve. Pak J Neurol Sci 2008;3:40-1.
8. 2*-weighted gradient echo magnetic resonance imaging. Curr Probl Diagn Radiol 2006;35:140-50.
9. Werring DJ. Cerebral microbleeds: clinical and pathophysiological significance. J Neuroimaging 2006;17:1-11.
10. Hortobagyi T, Al-Sarraj S. The significance of diffuse axonal injury: how to diagnose it and what does it tell us? Adv Clin Neurosci Rehabil 2008;8:16-18.
11. 2*-weighted gradient-echo imaging at 3 T. AJNR Am J Neuroradiol 2003;24:1049-56.
12. Clatterbuck RE, Eberhart CG, Crain BJ, Rigamonti D. Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations. J Neurol Neurosurg Psychiatry 2001;71:188-92.
13. Rigamonti D, Drayer BP, Johnson PC et al. The MRI appearance of cavernous malformations (angiomas). J Neurosurgery 1987;67:518-24.
14. Zabramaski JM, Wascher TM, Spetzler RF. The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurgery 1994;80:422-32.
15. Clatterbuck RE, Elmaci I, Rigamonti D. The nature and fate of punctate (type IV) cavernous malformations. Neurosurgery 2001;49:26-30.
16. Blitstein MK, Tung GA. MRI of cerebral microhaemorrhages. Am J Radiol 2007;189:720-5.
17. Haacke E., Xu Y, Cheng YC, Reichenbach JR. Susceptibility- weighted imaging (SWI). Magn Reson Med 2004;52:612-18.
18. Thomas B, Somasundaram S, Thamburaj K et al. Clinical applications of susceptibility weighted MR imaging of the brain: a pictorial review. Neuroradiology 2008;50:105-16.